Pataday Once Daily Relief®
olopatadine 0.2% · ophthalmic solution
Allergy
Approved uses
Itchy eyes due to pollen, ragweed, grass, animal hair and dander
1 drop in each affected eye QD
Itch relief is present at onset of action and still holds 16 hours after a single drop.
OFF-LABELNot in the FDA label for this product
Ocular redness of seasonal allergic conjunctivitis
1 drop in each affected eye QD, the labeled regimen, used for 10 weeks in the trial
RCT · n=260
Randomized, double-masked, placebo-controlled environmental trial across a spring grass season (N=260): on high pollen days 14% of treated patients rated redness frequency above 2 versus 31% on placebo (P<0.003), against 21% versus 47% for itching (P<0.001). The OTC Use statement on this product claims itch relief only, so redness is an unlabeled endpoint here.
Contraindications
Do not use if you are sensitive to any ingredient in this product.
Ophthalmic solution, 0.5 mL bottle, 2.5 mL bottle, 2.5 mL two bottle carton, 2.5 mL three bottle carton, 0.2% (2 mg/mL)
Selective histamine H1 receptor antagonist that also stabilizes conjunctival mast cells, blunting the response to histamine already released while limiting further degranulation. In human conjunctival mast cells the molecule inhibits histamine, tryptase and prostaglandin D2 release, and its H1 affinity (Ki 31.6 nM) far exceeds its H2 and H3 affinity.
Warnings & Precautions
- For external use only: For external use only.
- Do not use: Do not use if solution changes color or becomes cloudy, or to treat contact lens related irritation.
- Contamination: Do not touch tip of container to any surface to avoid contamination.
- Contact lens wear: Remove contact lenses before use, wait at least 10 minutes before reinserting contact lenses after use, and do not wear a contact lens if your eye is red.
- Stop use and ask a doctor: Stop use if you experience eye pain, changes in vision, increased redness of the eye, or itching that worsens or lasts for more than 72 hours.
- Keep out of reach of children: If swallowed, get medical help or contact a Poison Control Center right away.
Common Side Effects
- Challenge trial tolerability: No treatment-related adverse events among the 90 subjects in the conjunctival allergen challenge trial of this concentration.
- Seasonal use tolerability: In a 10 week environmental trial (N=260, including 28 subjects aged 11 to 17) no patient had a treatment-related serious adverse event and none discontinued for a treatment-related event.
Pregnancy: No data in this OTC label.
Lactation: No data in this OTC label.
Labeled for ages 2 and older.